Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 374 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/01/17
End: 02/01/35
Due: 02/01/36
Phase: N/A
Priority: Normal
Start: 08/24/18
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 09/17/24
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 10/18/18
End: 10/25/22
Due: 10/25/23
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 08/01/19
Due: 08/01/20
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 11/22/24
End: 07/31/29
Due: 07/31/30
Phase: N/A
Priority: Normal
Start: 05/28/25
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 01/31/20
End: 10/31/20
Due: 10/31/21
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 09/10/19
Due: 09/10/20
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 11/15/25
Due: 11/15/26
Phase: N/A
Priority: Normal
Start: 03/05/24
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 04/02/20
End: 02/21/21
Due: 02/21/22
Phase: N/A
Priority: Normal
Start: 08/18/23
End: 06/03/25
Due: 06/03/26
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 03/03/19
End: 03/27/20
Due: 03/27/21
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
Phase: N/A
Priority: Normal
Start: 02/28/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/05/17
End: 05/12/19
Due: 05/12/20